A randomized controlled trial of intranasal ketamine in major depressive disorder. - Wikidata - wikimedia - TriplyDB

A randomized controlled trial of intranasal ketamine in major depressive disorder.

A randomized controlled trial of intranasal ketamine in major depressive disorder.

http://www.wikidata.org/entity/Q34288196

about

Ketamine and other glutamate receptor modulators for depression in adults Treatment-Resistant Major Depression: Rationale for NMDA Receptors as Targets and Nitrous Oxide as Therapy Role of ketamine in acute postoperative pain management: a narrative review Beyond Monoamines-Novel Targets for Treatment-Resistant Depression: A Comprehensive Review Challenging Treatment-Resistant Major Depressive Disorder: A Roadmap for Improved Therapeutics Pharmacological approaches to the challenge of treatment-resistant depression Contribution of NMDA receptors to dorsolateral prefrontal cortical networks in primates A brief history of the development of antidepressant drugs: from monoamines to glutamate Case Reports Showing a Long-Term Effect of Subanesthetic Ketamine Infusion in Reducing l-DOPA-Induced Dyskinesias Oral Ketamine in Treatment-Resistant Depression: A Clinical Effectiveness Case Series Altered peripheral immune profiles in treatment-resistant depression: response to ketamine and prediction of treatment outcome.Experimental medication treatment approaches for depression.Adding low-field magnetic stimulation to noninvasive electromagnetic neuromodulatory therapies.Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics Glutamate NMDA receptor modulators for the treatment of depression: trials and tribulations.Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review.New targets for rapid antidepressant action.Emerging treatment mechanisms for depression: focus on glutamate and synaptic plasticity.Ketamine and Beyond: Investigations into the Potential of Glutamatergic Agents to Treat Depression.Ketamine as a promising prototype for a new generation of rapid-acting antidepressants.Is off-label repeat prescription of ketamine as a rapid antidepressant safe? Controversies, ethical concerns, and legal implications.Off-label use of transmucosal ketamine as a rapid-acting antidepressant: a retrospective chart review Novel Glutamatergic Treatments for Severe Mood Disorders.Effects of Low-Dose and Very Low-Dose Ketamine among Patients with Major Depression: a Systematic Review and Meta-Analysis.Efficacy of ketamine in the rapid treatment of major depressive disorder: a meta-analysis of randomized, double-blind, placebo-controlled studies.Therapeutic Modulation of Glutamate Receptors in Major Depressive Disorder Ketamine rapidly relieves acute suicidal ideation in cancer patients: a randomized controlled clinical trial.New drugs in psychiatry: focus on new pharmacological targets.Ameliorating treatment-refractory depression with intranasal ketamine: potential NMDA receptor actions in the pain circuitry representing mental anguish.The promise of ketamine for treatment-resistant depression: current evidence and future directions.The use of ketamine as an antidepressant: a systematic review and meta-analysis.Towards new mechanisms: an update on therapeutics for treatment-resistant major depressive disorder.Five potential therapeutic agents as antidepressants: a brief review and future directions.The promise and pitfalls of intranasally administering psychopharmacological agents for the treatment of psychiatric disorders.New Treatment Strategies of Depression: Based on Mechanisms Related to Neuroplasticity.Strategies to mitigate dissociative and psychotomimetic effects of ketamine in the treatment of major depressive episodes: a narrative review.Targeting glutamate signalling in depression: progress and prospects.Risks Associated with Misuse of Ketamine as a Rapid-Acting Antidepressant.Ketamine for treatment-resistant depression: recent developments and clinical applications.KETAMINE'S MECHANISM OF ACTION: A PATH TO RAPID-ACTING ANTIDEPRESSANTS.

P2860

Q24186746-FB308951-5206-40AB-BCC2-DFD3A4A219A4 Q26773084-A71B1E8F-389F-4CD0-8E09-522B6BED8AD3 Q26779981-08618ECE-A236-432F-ACF4-2D1C6A63F7A9 Q26782993-894C3567-2C05-4791-BFD1-C714E37C4F06 Q26782997-04638308-0EE0-4976-8531-73F3AADD1F05 Q26798241-A957743F-ABDA-440A-89F5-9583F035F22E Q26820417-0E088125-7938-4837-8428-30FDFD75D0AD Q27028050-FCB509D5-1346-4BC0-BEE9-DCCC41CBCD6C Q28828342-A7836417-73AF-4F1D-BEB9-DB675DF8D13E Q30491706-4EFCDBEF-98A9-435A-AAF7-58AA74AC9E4C Q33635571-AB0216C0-0DC4-4706-8EED-8B1F2B23EC7B Q33635577-782B46C1-82DF-4A18-BF4B-55F4D0E875D7 Q34428645-7629F63D-B32A-4114-9B21-52689723894A Q34444632-675B58A9-B22F-401E-812E-1BD2123E2C28 Q34466310-0A3694F4-9D7E-4A86-9E2A-04F3AE61823C Q34475595-D17BE409-DED2-4681-8AD8-4F5F5F779D94 Q34507177-FCAB96B0-E6C5-49C3-92DF-54BBD0F045DF Q34512818-E64DFC65-7E5D-4CCE-8C6F-E1560F41449E Q34551188-996A8D0E-3D85-49A3-B195-61B550EA1B51 Q35547495-EB55A540-B8F0-42D1-AB44-E7F5AAAC9DD5 Q35894579-0FD46C81-27A4-461E-896A-01441296A0D2 Q36176755-77D50CB6-FE77-41EA-A7CB-EA4C422E7DF3 Q36498659-886917CA-BC38-44B7-8A49-4CBCC157C3CC Q36852411-280CE806-FC38-4B8F-AB4A-CD35BE9E38B4 Q37398383-5159EEBC-B9EF-4FF5-98D9-58DF11D4772E Q37668014-3E8107F9-6867-4281-AEDA-38273B507ECB Q37709284-75123371-1FC8-41E3-988D-D61741A36375 Q37730207-A79EA469-E1DE-45F5-BAA4-70A57408FAF9 Q38331726-1DD89A3B-2E2B-4735-A49D-C922BFF286AD Q38343315-E751E9B4-AF8F-4E87-AFF1-AAEB53A4B196 Q38408563-094CA258-D6A3-49E0-891B-3FDCBDB7A499 Q38543238-D466E4DE-D483-40E2-A9A9-B675E4750717 Q38574831-CA0D43A8-1B68-4942-8631-3AB6BE1B7EB0 Q38629117-4C4528F6-B108-4BB6-AC79-617F02202191 Q38685420-3B84F062-2F5A-4A3A-A06B-A5E8AE1759B4 Q38692317-68EAD8C9-2443-42D8-A3B0-B7C9C7A24E67 Q38743867-C99D81F6-5BB2-4FA1-9144-FD341D002A12 Q38791739-91943E05-9F41-4B6C-AFB7-C98E356962FB Q38800172-4195273A-F582-45F3-A9B0-6EF21A3568A8 Q38803371-E2D22D61-C8D3-4D8B-9270-B4C020DA9E1C

P2860

A randomized controlled trial of intranasal ketamine in major depressive disorder.

http://www.wikidata.org/entity/Q34288196

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

A randomized controlled trial of intranasal ketamine in major depressive disorder.

@ast

A randomized controlled trial of intranasal ketamine in major depressive disorder.

@en

A randomized controlled trial of intranasal ketamine in major depressive disorder.

@nl

type

label

A randomized controlled trial of intranasal ketamine in major depressive disorder.

@ast

A randomized controlled trial of intranasal ketamine in major depressive disorder.

@en

A randomized controlled trial of intranasal ketamine in major depressive disorder.

@nl

prefLabel

A randomized controlled trial of intranasal ketamine in major depressive disorder.

@ast

A randomized controlled trial of intranasal ketamine in major depressive disorder.

@en

A randomized controlled trial of intranasal ketamine in major depressive disorder.

@nl

P1433

Q34288196-87FF9394-2752-4572-8262-68ED02DA998E

P1476

Q34288196-D22AA4F2-F207-42DD-991C-72EDD1F6BC92

P2093

Q34288196-3099C1D6-B5DF-4991-8C1D-9FED73A2FA17

Q34288196-3B20D52D-F7FA-43CF-B5E7-1EE8D2C19F02

Q34288196-4832B02B-6FC4-4397-8577-F925C5824595

Q34288196-81B34539-4383-424F-8AB8-6993D4CDDA9F

Q34288196-830A0340-BEEB-4F56-9C9B-BE672E96CA5D

Q34288196-891666F7-CD49-405E-9F56-3C9EF349F958

Q34288196-8C7F6909-A87D-4E0F-98C6-07E965BC243A

Q34288196-ABCF487B-911D-4B02-B53F-924A8062478B

Q34288196-D5DB07A1-AC76-4D83-9AEF-003DA6621CB6

Q34288196-D5F69EE8-378F-4E53-8388-E2D3D25440BE

P2860

Q34288196-023EBB99-C4F8-41AB-B15B-D6943A13F662

Q34288196-0F65B18D-A8EC-4E0A-B341-DD5203AEE827

Q34288196-10801D6F-A7D9-447B-B913-B86236613F32

Q34288196-13515BFF-D05D-4031-B1BA-92EDE074A384

Q34288196-1596A1DF-5411-4722-BCCB-444A73EE9BFF

Q34288196-15CB54FC-823D-47CF-B8C3-625CBEF5D418

Q34288196-1672A192-D2F3-4CE1-B449-393A5D99A30C

Q34288196-25B6FC6F-EF3F-4B09-AE58-13074FEF46CF

Q34288196-3130CB44-8EAB-482D-A206-A242CDA4BB3D

Q34288196-44A62E03-C202-4343-B74C-F4BA06C2C833

P304

Q34288196-2AC26BEE-B51F-4704-805D-D0A5D0C91B24

P31

Q34288196-9DDFEA3F-8CD3-4357-926C-24CD7D5E35DA

P356

Q34288196-0AA687A9-FF88-4FFF-BBCA-724F0AE99F0A

P407

Q34288196-4D244901-2DC2-4F33-9A76-417FDFD7E561

P433

Q34288196-C7707281-7E8C-426D-8D4C-40B14D58D278

P478

Q34288196-357CE117-7289-491B-AE6A-8FA3769CA05A

P577

Q34288196-FD67559A-DD4C-42DD-8F12-C285ABD94661

P5875

Q34288196-C8274E6C-10F8-46DF-B08A-2E6CDD4D86D0

P698

Q34288196-36378A1A-5E3B-4D06-A029-C71D7313EE68

P932

Q34288196-4FB005B1-E80D-4331-8AD3-8E8037650A8B

P356

J.BIOPSYCH.2014.03.026

P1433

Biological Psychiatry

P1476

A randomized controlled trial of intranasal ketamine in major depressive disorder.

@en

P2093

Adriana Feder

http://www.w3.org/2001/XMLSchema#string

Andrew M Perez

http://www.w3.org/2001/XMLSchema#string

Cara F Levitch

http://www.w3.org/2001/XMLSchema#string

Dan V Iosifescu

http://www.w3.org/2001/XMLSchema#string

Dennis S Charney

http://www.w3.org/2001/XMLSchema#string

James W Murrough

http://www.w3.org/2001/XMLSchema#string

Jess W Brallier

http://www.w3.org/2001/XMLSchema#string

Kyle A B Lapidus

http://www.w3.org/2001/XMLSchema#string

Laili Soleimani

http://www.w3.org/2001/XMLSchema#string

Michael K Parides

http://www.w3.org/2001/XMLSchema#string

P2860

Grand challenges in global mental health

Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial

A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression

Ketamine for treatment-resistant unipolar depression: current evidence

Subanesthetic dose of ketamine decreases prefrontal theta cordance in healthy volunteers: implications for antidepressant effect

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

Antidepressant effects of ketamine in depressed patients

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

Safety and efficacy of intranasal ketamine for the treatment of breakthrough pain in patients with chronic pain: a randomized, double-blind, placebo-controlled, crossover study.

The definition and meaning of treatment-resistant depression.

P304

970-976

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BIOPSYCH.2014.03.026

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

76

http://www.w3.org/2001/XMLSchema#string

P577

2014-04-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262266488

http://www.w3.org/2001/XMLSchema#string

P698

24821196

http://www.w3.org/2001/XMLSchema#string

P932

4185009

http://www.w3.org/2001/XMLSchema#string